NARAYANA HRUDAYALAYA
|
|
| BOM : 539551 NSE : NH | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Nov 01,2024 |
|
Price(EOD): ₹ 1,249.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 25,536.71 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NARAYANA HRUDAYALAYA | 0.6% | 1.6% | 27.8% |
| APOLLO HOSPITALS ENTERPRISE | 1.6% | 1.9% | 45.7% |
| MAX HEALTHCARE INSTITUTE | 4% | 7% | 77.3% |
| GLOBAL HEALTH | 3.9% | 14.6% | 40.9% |
| FORTIS HEALTHCARE | 5.2% | 6.4% | 94.4% |
| ASTER DM HEALTHCARE | 1.3% | 5.3% | 34.8% |
| DR LAL PATHLABS | -0.3% | -9.7% | 28.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 4.8% | 0.2% | 44.1% |
| RAINBOW CHILDRENS MEDICARE | 3.4% | 10.2% | 51.5% |
FUNDAMENTAL ANALYSIS OF NARAYANA HRUDAYALAYA
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NARAYANA HRUDAYALAYA
[As on : Nov 01,2024
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
32.77
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 779.18 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 8.85
P/B Calculated based on Book Value of Rs 2,883.53 Cr
[Latest Year - Mar2024 - Consolidated Results ] 4.89
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 5,224.01 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
22% 41% 43% |
SHARE PRICE MOMENTUM OF NARAYANA HRUDAYALAYA
NARAYANA HRUDAYALAYA vs SENSEX
DEBT OF NARAYANA HRUDAYALAYA
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2024 2023 2022 Avg_3yrs |
0.5 0.37 0.31 0.39 |
0.5 0.36 0.37 0.41 |
|
[Last Annual Data : Mar2024]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF NARAYANA HRUDAYALAYA
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Dec2023 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF NARAYANA HRUDAYALAYA
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.4% 1.5% 0.04% -1.34% |
7.26% 0.1% -6.69% -12.3% |
| QtrlyTrend |
2 | |
| Latest Qtr: Sep2024 | ||
| Quarterly Result Analysis → | ||
NARAYANA HRUDAYALAYA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 6.3% | -3.2% | 50.7% |
| S&P BSE 250 SMALLCAP | 5.3% | -3.7% | 47.2% |
| S&P BSE MIDSMALLCAP | 4.1% | -4.8% | 49.7% |
| S&P BSE 400 MIDSMALLCAP | 3.2% | -5.7% | 47.1% |
| S&P BSE HEALTHCARE | 3% | -0.4% | 61% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 5.6% | -3.3% | 48.9% |
| NIFTY SMALLCAP 50 | 5.4% | -2.3% | 55.8% |
| NIFTY FREE SMALL 100 | 5.1% | -2.9% | 48.2% |
| NIFTY MID SMALL400 | 3.4% | -5.1% | 46.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.3% | -5.5% | 39.3% |
You may also like the below Video Courses
FAQ about NARAYANA HRUDAYALAYA
Is NARAYANA HRUDAYALAYA good for long term investment?
As on Nov 01,2024, the Fundamentals of NARAYANA HRUDAYALAYA look Strong and hence it may be good for long term investment! See Financial Performance of NARAYANA HRUDAYALAYA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NARAYANA HRUDAYALAYA UnderValued or OverValued?
As on Nov 01,2024, NARAYANA HRUDAYALAYA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of NARAYANA HRUDAYALAYA ?
As on Nov 01,2024, the Intrinsic Value of NARAYANA HRUDAYALAYA is Rs. 885.75 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,027.53
Fair Value [Median EV / Sales Model] : Rs. 885.75
Fair Value [Median Price / Sales Model] : Rs. 870.70
Estimated Median Fair Value of NARAYANA HRUDAYALAYA : Rs. 885.75
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
